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Introduction: Although the syndrome of inappropriate antidiuretic hormone has connection with various
malignant tumors, there are few reports associated with advanced gastric cancer.
Case presentation: We describe the case of a 63-year-old Korean male with inappropriate antidiuretic hormone
syndrome due to an ectopic antidiuretic hormone-producing advanced gastric adenocarcinoma manifested with
overt serum hypo-osmolar hyponatremia and high urinary sodium concentrations. His adrenal, thyroidal, and renal
functioning were normal, and the hyponatremia improved following removal of the tumor. The cancer cells were
immunostained and found to be positive for the antidiuretic hormone. To our knowledge, this is the first report of
an antidiuretic hormone-secreting advanced gastric adenocarcinoma associated with the syndrome of inappropriate
antidiuretic hormone, showing cancer cells immunostained for the antidiuretic hormone.
Conclusions: Although a strong relationship between gastric cancer and the syndrome of inappropriate antidiuretic
hormone remains to be established, we suggest that gastric cancer could be included as a differential diagnosis of
cancer that is associated with the syndrome of antidiuretic hormone.
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The syndrome of inappropriate antidiuretic hormone
(SIADH) is characterized by the excessive release of
serum antidiuretic hormone (ADH) relative to serum
osmolality. It typically results in excessive water re-
absorption in the collecting ducts and hyponatremia.
SIADH is frequently found in patients diagnosed with
a variety of malignancies, including lung, brain, blad-
der, duodenum, pancreas, prostate, and head and neck
cancer, as well as lymphoma, leukemia, mesothelioma,
and thymoma [1,2]. However, there are very few reports
of SIADH associated with advanced gastric cancer
(AGC) [3-5].* Correspondence: drpdj@korea.com
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A 63-year-old Korean male was admitted to our hospital
with anorexia, generalized weakness, and melena that
began three days prior to admission. The patient had been
admitted to the emergency room three months prior due
to nausea and vomiting. His serum sodium level was
114mEq/L, osmolality was 250mOsm/kg, and uric acid
was 2.9mg/dL. Tests revealed urine osmolality and sodium
to be 390mOsm/kg and 57mEq/L, respectively. These la-
boratory results were consistent with SIADH. Despite a
recommendation for further evaluation, the patient re-
fused to be admitted to the hospital. He was subsequently
discharged after his symptoms subsided and his sodium
levels were restored to 122mEq/L following an infusion of
3% saline.
Upon admission, the patient did not display signs of
dehydration or over-hydration. The patient did not have
an underlying disease, such as diabetes, hypertension,
chronic hepatitis, renal disease, or chronic lung disease,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a contributing family history. His blood pressure was
130/80mmHg, his pulse rate was 78 beats per minute,
and his body temperature was 36.7°C. His physical and
neurological examinations were normal. Laboratory tests
revealed the following: hemoglobin 13.4g/dL, platelets
159×103/mm3, white blood cells 6,700/mm3 (30% neu-
trophils, 52% lymphocytes), serum sodium 109mEq/L,
potassium 3.6mEq/L, chloride 71.4mEq/L, osmolality
223mOsm/kg, uric acid 2.4mg/dL, alkaline phosphatase
(ALP) 110U/L, aspartate transaminase (AST) 23U/L,
alanine transaminase (ALT) 29U/L, total protein 7.3g/dL,
albumin 3.9g/dL, creatinine 0.9mg/dL, urine sodium
52.4mEq/L, and osmolality 345mOsm/kg. His serum
sodium level increased to 121mEq/L following a two-
day infusion of 3% saline, and his plasma ADH level
(Kit; BÜHLMANN, method: RIA (radio-immunoassay),
Schönenbuch, Switzerland) was 11.18pg/mL (0 to 6.7) at
that time. Thyroid function tests revealed his thyroid-
stimulating hormone (TSH) level to be 1.02μU/mL (0.27
to 4.2), free T4 to be 1.28μU/mL (0.93 to 1.70), and a total
T3 of 91.02μU/mL (80 to 200). An adrenocorticotropic
hormone (ACTH) stimulation test demonstrated that his
basal cortisol level was 22.64μg/dL. Moreover, his cortisol
level was 27.89μg/dL at 30 minutes following ACTH ad-
ministration (250μg), and 33.73μg/dL at 60 minutes after
ACTH administration. His prostate-specific antigen (PSA)
level was 1.80ng/mL. His serum sodium level partially
recovered to 127mEq/L by water restriction prior to
surgery.
A gastroendoscopy procedure revealed an ulceroinfil-
trative lesion on the lesser curvature of the upper high
body, with irregular margins and a diameter of 2.5×2.5cm
(Figure 1). Bleeding was found to be present at the cen-
ter of the ulceration. A biopsy revealed a moderatelyFigure 1 A gastrofibroscopy shows an ulceroinfiltrative lesion
with active oozing bleeding. The lesion was roughly 2.5 × 2.5cm
in size and located at the center of a defective ulcer base of the
lesser curvature of the high body.differentiated adenocarcinoma. A computed tomography
(CT) scan revealed a thickened wall on the lesser cur-
vature of the high body (Figure 2). A laparoscopic total
gastrectomy and Roux-en Y esophago-jejunostomy was
performed. Tumor cells were found to have infiltrated the
subserosa and had metastasized to a single perigastric
lymph node, resulting in stage T3N1M0 cancer. His so-
dium level and ADH level normalized to 135mEq/L and
5.9pg/mL respectively, three weeks following the surgery
(Table 1). Retrospective immunohistochemical staining
of the cancer cells were positive for the ADH protein
(H-300, Santa Cruz Biotechnology, Santa Cruz, CA,
United States) (Figure 3a). No staining was detected
on the normal gastric cells (Figure 3b). He died due to
cancer progression 1.6 years later after diagnosis despite
operation and chemotherapy.
Discussion
Our case report details a patient with SIADH associated
with an AGC. This was confirmed by 1) hypo-osmolar
hyponatremia, hypouricemia, high urinary sodium con-
centration and concentrated urine; 2) normal adrenal,
thyroid, and renal function; 3) inappropriate secretion of
ADH under hyponatremia; 4) positive immunostaining
of the cancer cells with an anti-ADH antibody; 5) a full
restoration of serum sodium concentration and ADH
levels following the removal of the tumor. To the best of
our knowledge, this is the first report of AGC associated
with SIADH that was histologically confirmed by anti-
ADH immunostaining of the tumor cells.
SIADH is often regarded as a diagnosis of exclusions.
First, adrenal and thyroid diseases with associated hypo-
natremia should be excluded. Various medical conditions
should be considered in relation to SIADH, including [2]:
1) ectopic secretion of ADH (released from tumor tissue,Figure 2 An axial computational tomography scan of the lesser
curvature of the high body in the stomach. The fat plane is
preserved. No lymphadenopathy is seen. Scan shows thickening
(arrow) and mucosal enhancement.













Serum sodium (mEq/L) 109 121 128 131 134 135
Serum osmolality (mOsm/kg) 223 250 264 276 NA NA
Urine sodium (mEq/L) 52.4 76.3 73.2 NA NA NA
Urine osmolality (mOsm/kg) 325 356 337 NA NA NA
Plasma ADH level (pg/mL) NA 11.18 NA NA NA 5.9
ADH, antidiuretic hormone; NA, not available; OP, operation.
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sure, such as with a pneumothorax or status asthmaticus);
2) increased hypothalamic production of ADH-like sub-
stances associated with neurological disorders (infections,
Guillain-Barre syndrome, and brain tumors); 3) medica-
tions (cytotoxic agents, carbamazepine, chlorpropamide,
clofibrate, narcotics, and sulfonylurea); and 4) administra-
tion of exogenous ADH or oxytocin. Excluding gastric
cancer, several conditions were ruled out in the present
case by verifying hormone levels and conducting a thor-
ough medical history, physical examination, and labora-
tory and radiological tests. Importantly, his hyponatremia
and elevated serum ADH levels improved following the
removal of the tumor, indicating that the hyponatremia
was associated with the ADH-secreting cancer cells.
Excessive ADH secretion is often found in tumors with
ectopic hormone production. Three clinical conditions
are necessary for a tumor with ectopic ADH production
[6]. These criteria include SIADH as a clinical symptom
of hormone recovery of hyponatremia after removal of
the tumor. The hyponatremia present in our patient was
due to ADH-secreting cancer cells.
A previous study including a large number of SIADH
patients reported that SIADH occurs in 3% of patients
with head and neck cancer, 0.7% of patients with non-
small-cell lung cancer, and 15% of patients with small-
cell lung cancer [1]. The relationship between SIADH and
gastric cancer, however, is not well established. Anti-ADHFigure 3 Immunostainings of cancer and normal gastric cells. (a) Can
magnification). (b) Normal gastric cells negative for the antidiuretic hormantibodies have not been used to detect ADH in cancer
tissue in the three cases of gastric cancer that have been
reported since 1990. Here, we demonstrated hyponatre-
mia with ADH-stained gastric cancer cells. Although the
rate of gastric cancer is decreasing, it is still the most com-
mon type of cancer in Korea. According to the Korean
Ministry of Health and Welfare 2010 report, stomach can-
cer is the leading cause of cancer with an incidence of
15.7%. The use of a gastric endoscopy is difficult to en-
force due to the high incidence of stomach cancer. How-
ever, the lower incidence of hyponatremia in our case
describes a patient who initially presented with symptoms
of nausea and vomiting associated with hyponatremia,
which lead to a diagnosis of AGC three months later.Conclusions
Although a strong relationship between gastric cancer
and SIADH remains to be established, we suggest that
gastric cancer could be included as a differential diagno-
sis of cancer that is associated with SIADH.Consent
Written informed consent was obtained from the pa-
tient’s next-of-kin for publication of this case report
and accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of
this journal.cer cells positive for the antidiuretic hormone protein (×200
one protein (×200 magnification).
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